News

ThreeD Capital Highlights Impressive Annual Growth in 2024

ThreeD Capital Highlights Impressive Annual Growth in 2024

ThreeD Capital Report on Recent Financial Outcomes for 2024

Toronto-based ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK / OTCQX:IDKFF) has released its audited financial results for the latest fiscal year, ending June 30, 2024. The venture capital firm specializes in identifying promising investment opportunities within both junior resources and disruptive technology sectors.

Financial Status Overview

As of June 30, 2024, ThreeD Capital boasted an impressive portfolio consisting of cash, investments, and digital assets totaling $55.2 million. This figure highlights the company’s robust financial health and strategic investments made throughout the fiscal year.

Growth in Net Asset Value

The net asset value per share as of June 30, 2024, was reported at $0.86, demonstrating an increase from $0.79 during the same period last year. This growth underscores the firm’s successful investment strategies and emphasizes its robust financial position.

Key Financial Highlights

ThreeD Capital also showcased several notable financial metrics for the year with comparative figures from the previous year:

  • Net investment and digital asset gains (losses): $(6,259,447) compared to $(9,378,547) in the previous year.
  • Operating expenses: $(4,257,862), up from $(3,206,217).
  • Net income (loss) for the period: $4,017,533 compared to $(12,292,559).
  • Total comprehensive income (loss): $4,016,934 versus $(12,293,033).

Shareholder Returns

Amidst the financial progress, the basic income (loss) per common share stood at $0.08, a significant improvement over the previous loss of $(0.25) per share.

Strategic Insights and CEO Remarks

Sheldon Inwentash, Chairman and CEO of ThreeD, remarked on the company’s fruitful year. He noted, “ThreeD experienced significant growth throughout the year ended June 30, 2024. Our investments increased by 44% compared to last year, validating our strategy to target and invest in companies involved in disruptive technologies that have the potential for high returns.” This sentiment reflects a strong confidence in the company’s direction and the quality of its investment decisions.

Non-GAAP Financial Measures Explanation

This financial report uses “net asset value per share” (NAV), which is a non-GAAP measure. It's calculated by taking total assets, subtracting total liabilities, and then dividing by the total number of shares outstanding. While NAV is a useful indicator for shareholders to evaluate ThreeD’s performance, it may not be directly comparable to similar measures used by other companies.

About ThreeD Capital

ThreeD Capital Inc. specializes in opportunistic venture capital investments, focusing on early-stage companies within the junior resources and disruptive technology spaces. By taking a hands-on approach and often serving as the lead investor, ThreeD provides companies not just with funding but also advisory services and access to a broader network.

Contact Details for Inquiries

If you wish to know more about ThreeD Capital, feel free to reach out to:
Matthew Davis, CPA
Chief Financial Officer
Email: davis@threedcap.com
Phone: 416-941-8900

Frequently Asked Questions

What are the key financial highlights for ThreeD Capital in 2024?

Key highlights include a net asset value of $0.86 per share and a total cash and asset position of $55.2 million.

How did ThreeD Capital's performance change compared to the previous year?

ThreeD Capital saw a 44% increase in investments compared to the prior year, improving its financial position significantly.

What is the company’s investment strategy?

ThreeD Capital targets early-stage companies in junior resources and disruptive technologies, often taking an active role as lead investor.

How does the company evaluate its financial performance?

ThreeD uses net asset value per share (NAV) as its primary measure, which provides insights into the company’s financial health.

Who should I contact for more information about ThreeD Capital?

For inquiries, you can reach Matthew Davis, CFO, at davis@threedcap.com or by phone at 416-941-8900.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 136

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 288

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 201

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 202

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 205

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 148

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 215

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 138

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Travel: The Rise of Recreational Vehicles

Updated Category News Views 118

Understanding the Recreational Vehicle Market The recreational vehicle (RV) market has become a beacon for travel enthusiasts, illustrating a profound shift toward enhancing the travel experience. These vehicles offer not just transportation, but a home on wheels, combining adventure with convenience. As of now, the global RV market size is valued significantly, with...

Continue Reading
Explore Data Quality Trends at FWRD 2025 Virtual Event

Updated Category News Views 245

Ataccama Opens Registration for FWRD 2025 BOSTON — Ataccama, the data trust company, is excited to announce that registration is now open for FWRD 2025, its major virtual event designed for Chief Data Officers (CDOs) and data leaders navigating the complexities of artificial intelligence and data management. This groundbreaking event will take place on November 6 and...

Continue Reading
Enhancements in Event Ticketing with Apple Wallet and Ticketmaster

Updated Category News Views 125

Exciting Changes in Ticketing with Apple Wallet Live Nation Entertainment’s Ticketmaster has announced a significant enhancement for event ticketing by integrating support for richer tickets within Apple Inc.’s Wallet. This upgrade, stemming from the new features introduced with iOS 18, is set to revolutionize how concert and event goers manage their tickets. What...

Continue Reading
Zealand Pharma To Host Conference Call for Q2 2025 Results

Updated Category News Views 183

Zealand Pharma's Upcoming Conference Call Zealand Pharma A/S, a prominent biotechnology firm known for its innovative peptide-based medicines, has announced an important event on August 14, 2025. The company will hold a conference call at 2:00 PM CET, equivalent to 8:00 AM ET, to discuss its financial results for the second quarter of 2025. Key Participants in the Call...

Continue Reading
Juniper Biosciences Secures $40 Million for Future Projects

Updated Category News Views 249

Juniper Biosciences Secures Significant Funding In a remarkable move to propel its innovative projects forward, Juniper Biosciences LLC has successfully closed an oversubscribed and upsized $40 million seed financing round. This effort was spearheaded through its parent company, Juniper Radiopharma LLC, and co-led by NovaCapital alongside several high-net-worth investors...

Continue Reading